WO2001013714A3 - Lignee cellulaire prostatique et modele animal de tumeur prostatique - Google Patents

Lignee cellulaire prostatique et modele animal de tumeur prostatique Download PDF

Info

Publication number
WO2001013714A3
WO2001013714A3 PCT/FR2000/002362 FR0002362W WO0113714A3 WO 2001013714 A3 WO2001013714 A3 WO 2001013714A3 FR 0002362 W FR0002362 W FR 0002362W WO 0113714 A3 WO0113714 A3 WO 0113714A3
Authority
WO
WIPO (PCT)
Prior art keywords
prostatic
cell line
tumor
animal model
prostatic tumor
Prior art date
Application number
PCT/FR2000/002362
Other languages
English (en)
Other versions
WO2001013714A2 (fr
Inventor
Olivier Cussenot
Jean-Marie Villette
Original Assignee
Urogene
Olivier Cussenot
Jean-Marie Villette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogene, Olivier Cussenot, Jean-Marie Villette filed Critical Urogene
Priority to JP2001517868A priority Critical patent/JP2003513616A/ja
Priority to EP00958727A priority patent/EP1244350A2/fr
Priority to CA002382204A priority patent/CA2382204A1/fr
Priority to IL14832300A priority patent/IL148323A0/xx
Priority to AU70158/00A priority patent/AU7015800A/en
Publication of WO2001013714A2 publication Critical patent/WO2001013714A2/fr
Priority to US10/081,348 priority patent/US20030013191A1/en
Publication of WO2001013714A3 publication Critical patent/WO2001013714A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention se rapporte à un procédé de production d'un animal mammifère non humain A porteur d'une tumeur prostatique, à une lignée cellulaire établie susceptible, après greffage, de former une tumeur prostatique chez le chien, à des anticorps monoclonaux spécifiques des cellules tumorales prostatiques, et à l'utilisation de ces derniers en diagnostic ou en thérapeutique.
PCT/FR2000/002362 1999-08-23 2000-08-23 Lignee cellulaire prostatique et modele animal de tumeur prostatique WO2001013714A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2001517868A JP2003513616A (ja) 1999-08-23 2000-08-23 前立腺細胞系統及び動物において確立された前立腺腫瘍の獲得を目的とするその利用
EP00958727A EP1244350A2 (fr) 1999-08-23 2000-08-23 Lignee cellulaire prostatique et modele animal de tumeur prostatique
CA002382204A CA2382204A1 (fr) 1999-08-23 2000-08-23 Lignee cellulaire prostatique et son utilisation pour l'obtention d'une tumeur prostatique etablie chez un animal
IL14832300A IL148323A0 (en) 1999-08-23 2000-08-23 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
AU70158/00A AU7015800A (en) 1999-08-23 2000-08-23 Prostatic cell line and use thereof to obtain an established prostatic cancer inan animal
US10/081,348 US20030013191A1 (en) 1999-08-23 2002-02-22 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910700A FR2797743B1 (fr) 1999-08-23 1999-08-23 Lignee cellulaire prostatique et son utilisation pour l'obtention d'une tumeur prostatique etablie chez l'animal
FR99/10700 1999-08-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/081,348 Continuation US20030013191A1 (en) 1999-08-23 2002-02-22 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal

Publications (2)

Publication Number Publication Date
WO2001013714A2 WO2001013714A2 (fr) 2001-03-01
WO2001013714A3 true WO2001013714A3 (fr) 2002-08-08

Family

ID=9549284

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/002362 WO2001013714A2 (fr) 1999-08-23 2000-08-23 Lignee cellulaire prostatique et modele animal de tumeur prostatique

Country Status (8)

Country Link
US (1) US20030013191A1 (fr)
EP (1) EP1244350A2 (fr)
JP (1) JP2003513616A (fr)
AU (1) AU7015800A (fr)
CA (1) CA2382204A1 (fr)
FR (1) FR2797743B1 (fr)
IL (1) IL148323A0 (fr)
WO (1) WO2001013714A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7660621B2 (en) 2000-04-07 2010-02-09 Medtronic, Inc. Medical device introducer
US20050215472A1 (en) * 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
EP3184539A3 (fr) * 2001-10-23 2017-09-13 PSMA Development Company L.L.C. Anticorps contre le psma
US7704260B2 (en) 2002-09-17 2010-04-27 Medtronic, Inc. Low profile instrument immobilizer
US7580756B2 (en) 2004-02-13 2009-08-25 Medtronic, Inc. Methods and apparatus for securing a therapy delivery device within a burr hole
EP1726650A1 (fr) * 2005-05-27 2006-11-29 Universitätsklinikum Freiburg Anticorps monoclonaux et fragments d'anticorps monocaténaires contre l'antigène spécifique de surface membranaire de la prostate
US20110189093A1 (en) * 2008-04-14 2011-08-04 Proscan Rx Pharma Prostate specific membrane antigen antibodies and antigen binding fragments

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035616A1 (fr) * 1996-03-25 1997-10-02 Pacific Northwest Cancer Foundation Anticorps monoclonaux de l'antigene membranaire specifique de la prostate
WO1998016628A1 (fr) * 1996-10-15 1998-04-23 The Regents Of The University Of California Modeles animaux de la progression du cancer de la prostate chez l'humain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846535A (en) * 1990-10-12 1998-12-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035616A1 (fr) * 1996-03-25 1997-10-02 Pacific Northwest Cancer Foundation Anticorps monoclonaux de l'antigene membranaire specifique de la prostate
WO1998016628A1 (fr) * 1996-10-15 1998-04-23 The Regents Of The University Of California Modeles animaux de la progression du cancer de la prostate chez l'humain

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AN Z ET AL: "SURGICAL ORTHOTOPIC IMPLANTATION ALLOWS HIGH LUNG AND LYMPH NODE METASTATIC EXPRESSION OF HUMAN PROSTATE CARCINOMA CELL LINE PC-3 IN NUDE MICE", PROSTATE, WILEY-LISS, NEW YORK, NY, US, vol. 34, no. 3, 15 February 1998 (1998-02-15), pages 169 - 174, XP001019739, ISSN: 0270-4137 *
ANIDJAR MAURICE ET AL.: "In vivo model mimicking natural history of dog prostate cancer", PROSTATE, vol. 46, no. 1, January 2001 (2001-01-01), pages 2 - 10, XP001019730 *
EATON, C.L. & PIERREPOINT, C.G.: "Growth of a spontaneous Canine prostatic adenocarcinoma in vivo and in vitro : isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1", THE PROSTATE, vol. 12, no. 2, 1988, pages 129 - 143, XP000909284 *
ISRAELI,R.S., POWELL,C.T., FAIR,W.R. AND HESTON,W.D.: "Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen", CANCER RES. 53 (2), 227-230 (1993), XP000645134 *
NAVONE N M ET AL: "MODEL SYSTEMS OF PROSTATE CANCER: USES AND LIMITATIONS", CANCER METASTASIS, KLUWER ACADEMIC PUBLISHERS, DORDRECHT, NL, vol. 17, no. 4, 1999, pages 361 - 371, XP001019751, ISSN: 0167-7659 *
SATO, N. ET AL.: "Metastatic and androgen-sensitive human prostate cancer animal model using orthotopic inoculation of LNCaP cells in SCID mice", THE JOURNAL OF UROLOGY, vol. 155, no. 5 suppl., May 1996 (1996-05-01), pages 338a, XP000909151 *
VAN WEERDEN, W. ET AL.: "Development of seven new human prostate tumor xenograft models and their histopathological characterization", AMERICAN JOURNAL OF PATHOLOGY, vol. 149, no. 3, September 1996 (1996-09-01), pages 1055 - 1062, XP000910303 *

Also Published As

Publication number Publication date
FR2797743B1 (fr) 2003-08-08
CA2382204A1 (fr) 2001-03-01
JP2003513616A (ja) 2003-04-15
EP1244350A2 (fr) 2002-10-02
WO2001013714A2 (fr) 2001-03-01
IL148323A0 (en) 2002-09-12
US20030013191A1 (en) 2003-01-16
FR2797743A1 (fr) 2001-03-02
AU7015800A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
HK1008472A1 (en) Chimeric animal and method for constructing the same
WO2004016742A3 (fr) Cellules depourvues d'$g(a)(1,3)-galactosyltransferase, procedes de selection et porc depourvu d'$g(a)(1,3)-galactosyltransferase ainsi obtenu
NZ502124A (en) Cloning pigs using donor nuclei from differentiated cells
CA2300705A1 (fr) Curietherapie 3d peroperatoire de la prostate, effectuee sous echoguidage
WO2002078449A3 (fr) Procede permettant de faciliter la production de types de cellules et de tissus differencies a partir de cellules pluripotentes et multipotentes embryonnaires et adultes
WO2000031237A3 (fr) Procede de clonage de porcins
WO2003045427A3 (fr) Composition pharmaceutique servant a induire une reponse immune chez l'homme ou chez l'animal
DE69838953D1 (de) Methoden zur herstellung von glykosylierten antikörpern und antikörperfragmenten mit reaktiven ketongruppen
EP0832203A4 (fr) Utilisation de lignees de cellules neuroderivees de f tus dans une therapie de transplantation
CA2073124A1 (fr) Anticorps specifique d'un antigene tumoral
GB9903955D0 (en) Methods and means for producing cellular and animal models for neurodengenerative diseases
EP1198169A4 (fr) Processus de reprogrammation cellulaire par production d'un heterocaryon
ATE332077T1 (de) Transgene mäuse die ein menschliche antikörper exprimieren
WO2003089580A3 (fr) Modeles de cancer
WO2002010337A3 (fr) Methode de clonage de porcs
WO2001013714A3 (fr) Lignee cellulaire prostatique et modele animal de tumeur prostatique
WO2000078119A3 (fr) Cardiomyocytes a potentiel de proliferation renforce, leur obtention et leur utilisation
TR199601037A2 (tr) Suda cözülebilir azo boyarmaddeleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmasi.
WO2003022220A3 (fr) Procede de generation d'un animal de betail transgenique
MXPA02006094A (es) Metodos para producir embriones clonadod y adultos a partir de celulas cultivadas.
AU2001262726A1 (en) Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
EP0983352A4 (fr) Sequences d'acide nucleique regulatrices specifiques de la prostate et animaux transgeniques non humains exprimant l'antigene prostatique specifique
AU9374198A (en) Methods for producing human antibodies in scid mice using dendritic cells
WO2005113753A3 (fr) Cellules souches prostatiques, isolation et utilisations
EP1512755A3 (fr) Marqueurs moléculaires du cancer de la prostate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 148323

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 10081348

Country of ref document: US

Ref document number: 2382204

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000958727

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 70158/00

Country of ref document: AU

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000958727

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000958727

Country of ref document: EP